pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
ervaxx PRESS RELEASE ARCHIVE
Jan 24, 2020
Ervaxx and Cardiff University Enter Collaboration to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens™
Nov 6, 2019
Ervaxx Launches to Pioneer the Use of Dark Antigens™ for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies
